VIN has been shown to improve memory and brain processing speed. It also increases brain glucose metabolism and increases the mitochondria’s generation ATP, which can improve brain energy as well as mood, memory and other mental functions. It is also a powerful anti-oxidant, and neuro-protective agent that has been shown to protect brain cells against the chronic age-related reduction in oxygen levels.

References:

Subhan Z, Hindmarch H. Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology, 1985, Sept;28(5):567-571

DeNoble VJ, Repetti SJ, Gelpke LW, Wood LM, Keim KL. Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats. Pharmacol Biochem Behav.1986.Apr;24(4):1123-8.

Polich J, Gloria R. Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. Human Psychopharmacology:Clinical and Experimental. 1991;16(5):409-416

Coleston D, Hindmarch I. Possible memory-enhancing properties of vinpocetine. Drug Development Research 2004 Oct; 14(3-4):191-193

Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc. 1987 May;35(5):425-30.

Lendvai B, Zelles T, Rozsa B, Vizi ES. A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells. Brain Res Bull. 2003 Jan 15;59(4):257-60

Horvath, Beata : Marton, Zsolt : Halmosi, Robert : Alexy, Tamas : Szapary, Laszlo : Vekasi, Judit : Biro, Zsolt : Habon, Tamas : Kesmarky, Gabor : Toth, Kalman. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clin-Neuropharmacol. 2002 Jan-Feb; 25(1): 37-42

Zelles, T : Franklin, L : Koncz, I : Lendvai, B : Zsilla, G. The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells. Neurochem-Res. 2001 Sep; 26(8-9): 1095-100

Pereira, C : Agostinho, P : Oliveira, CR. Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells. Free-Radic-Res. 2000 Nov; 33(5): 497-506

Santos , M S : Duarte, A I : Moreira, P I : Oliveira, C R. Synaptosomal response to oxidative stress: effect of vinpocetine. Free-Radic-Res. 2000 Jan; 32(1): 57-66

Hayakawa, M. Comparative efficacy of vinpocetine, pentoxifylline and nicergoline on red blood cell deformability. Arzneimittelforschung. 1992 Feb; 42(2): 108-10

Kiss, B : Cai, N S : Erdo, S L. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies. Eur-J-Pharmacol. 1991 Dec 10; 209(1-2): 109-12

Rischke, R : Krieglstein, J. Protective effect of vinpocetine against brain damage caused by ischemia. Jpn-J-Pharmacol. 1991 Jul; 56(3): 349-56

Hitzenberger, G : Sommer, W : Grandt, R. Influence of vinpocetine on warfarin-induced inhibition of coagulation. Int-J-Clin-Pharmacol-Ther-Toxicol. 1990 Aug; 28(8): 323-8

Yasui, M : Yano, I : Ota, K : Oshima, A. Calcium, phosphorus and aluminium concentrations in the central nervous system, liver and kidney of rabbits with experimental atherosclerosis: preventive effects of vinpocetine on the deposition of these elements. J-Int-Med-Res. 1990 Mar-Apr; 18(2): 142-52

Gaal, L : Molnar, P. Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus. Eur-J-Pharmacol. 1990 Oct 23; 187(3): 537-9

Gabryel, B : Adamek, M : Pudelko, A : Malecki, A : Trzeciak, H I. Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology. 2002 May; 23(1): 19-31.